Frédéric Fiteni
Impact in
- Oncology top 10%
- Cancer survivorship and care
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
- Gallbladder and Bile Duct Disorders
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 27
- Cancer survivorship and care 7
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 5
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 4
- Co-authors
- Franck Bonnetain (18 shared papers)Virginie Westeel (11 shared papers)Christophe Borg (9 shared papers)Amélie Anota (7 shared papers)Xavier Pivot (9 shared papers)Déwi Vernerey (5 shared papers)Sophie Paget‐Bailly (4 shared papers)Zeinab Hamidou (2 shared papers)
- Journals
- The Breast (3 papers)Journal of Clinical Oncology (3 papers)European Journal of Cancer (3 papers)Expert Review of Anticancer Therapy (3 papers)BMC Cancer (2 papers)
- Partner nations
- FranceBelgiumNetherlands
In The Last Decade
Frédéric Fiteni
37 papers receiving 600 citations
Peers
Comparison fields: 5 of 85
- Oncology 346
- Pulmonary and Respiratory Medicine 266
- Geriatrics and Gerontology 27
- Cancer Research 85
- Statistics and Probability 44
Countries citing papers authored by Frédéric Fiteni
This map shows the geographic impact of Frédéric Fiteni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Fiteni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Fiteni more than expected).
Fields of papers citing papers by Frédéric Fiteni
This network shows the impact of papers produced by Frédéric Fiteni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Fiteni. The network helps show where Frédéric Fiteni may publish in the future.
Co-authors
The 25 scholars most cited alongside Frédéric Fiteni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 83 | |
| 2 | 2014 | 81 | |
| 3 | 2014 | 58 | |
| 4 | 2019 | 57 | |
| 5 | 2015 | 35 | |
| 6 | 2016 | 31 | |
| 7 | 2019 | 27 | |
| 8 | 2018 | 20 | |
| 9 | 2014 | 19 | |
| 10 | 2017 | 19 | |
| 11 | 2016 | 15 | |
| 12 | 2016 | 14 | |
| 13 | 2019 | 14 | |
| 14 | 2021 | 14 | |
| 15 | 2015 | 13 | |
| 16 | 2015 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2018 | 11 | |
| 19 | 2016 | 11 | |
| 20 | 2022 | 9 |
About Frédéric Fiteni
Frédéric Fiteni is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Economics and Econometrics, having authored 41 papers that have together received 611 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer survivorship and care (7 papers), Statistical Methods in Clinical Trials (6 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (346 citations), Pulmonary and Respiratory Medicine (266 citations), Geriatrics and Gerontology (27 citations), Cancer Research (85 citations) and Statistics and Probability (44 citations). Frédéric Fiteni has collaborated with scholars based in France, Belgium and Netherlands. Frequent co-authors include Franck Bonnetain, Virginie Westeel, Christophe Borg, Amélie Anota, Xavier Pivot, Déwi Vernerey, Sophie Paget‐Bailly, Zeinab Hamidou, Caroline Mollévi and Stéfano Kim. Their work appears in journals such as The Breast, Journal of Clinical Oncology, European Journal of Cancer, Expert Review of Anticancer Therapy and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.